While federal regulators have induced pharmaceutical companies to conduct hundreds of studies on some 200 drugs, another two-thirds of the thousands of children's medicines remain untested, The Washington Post
"Are there children dying because of this? I don't know. Are there children being less effectively treated because of this? Probably, yes," Richard Gorman of the American Academy of Pediatrics said in the Post. "That's the problem: We don't know what we don't know."